旅行疫苗市場規模、佔有率和成長分析（按疫苗類型、疾病、旅行者類型和地區分類）－2026-2033年產業預測

全球旅遊疫苗市場規模預計在 2024 年達到 43.1 億美元，從 2025 年的 45.4 億美元成長到 2033 年的 68.1 億美元，在預測期（2026-2033 年）內複合年成長率為 5.2%。

全球旅行疫苗市場正經歷顯著成長，這主要受多種因素影響，包括供需兩端。休閒、商務和教育等國際旅行的激增推動了對特定地點疫苗的需求，這對於預防當地感染至關重要。全球旅遊業的蓬勃發展，尤其是生態旅遊和探險旅遊，進一步凸顯了疫苗接種的必要性。民眾和政府對感染疾病疫情的日益關注也推動了全球疫苗需求。此外，各國對疫苗接種證書的監管要求也創造了合規性和市場機會。疫苗研發技術的創新，包括mRNA和重組技術，提高了疫苗的效力並加快了生產速度，增加了人們對這些疫苗的依賴。不斷上漲的醫療保健成本以及旨在加強旅行者教育的公共衛生舉措也促進了市場成長。

全球旅行疫苗市場促進因素

全球旅行疫苗市場的主要促進因素是各地感染疾病日益流行，以及人們對安全旅行體驗的需求不斷成長。隨著國際旅行的日益便捷，旅客對目的地特定疾病帶來的健康風險也越來越重視。這種日益增強的意識，加上各國政府為推廣旅遊相關疾病疫苗接種所採取的舉措，正在推動疫苗需求的成長。此外，鑑於近期新冠疫情，全球疫苗接種運動進一步增加了旅客接種必要疫苗的需求，從而促進了市場成長，因為醫療服務提供者和旅客都在尋求積極主動的措施來確保旅行期間的健康安全。

限制全球旅行疫苗市場的因素

全球旅行疫苗市場的主要限制因素之一是疫苗猶豫情緒日益高漲，這主要是由於關於疫苗的錯誤訊息和文化觀念造成的。這種日益成長的懷疑影響了旅客在旅行前接種所需疫苗的意願，最終限制了市場的成長潛力。此外，與疫苗相關的爭議不斷增加，反疫苗情緒透過社群媒體平台傳播，進一步加劇了公眾的焦慮，導致疫苗接種率下降。因此，醫療服務提供者在推廣旅遊疫苗方面可能會面臨挑戰。由於潛在旅行者更傾向於個人信念和錯誤訊息而非醫療建議，整體市場擴張和公共衛生舉措可能會受到阻礙。

全球旅行疫苗市場趨勢

隨著mRNA、重組和單劑量平台等先進疫苗技術的整合，全球旅行疫苗市場正經歷重大變革時期。這些創新透過提高疫苗穩定性增強其效力，最佳化分發能力，並能對新出現的健康威脅做出快速反應。鑑於mRNA平台在新冠疫情期間取得的顯著成功，領先的製藥公司正在加大對新型和結合型旅遊疫苗的研發投入。這種積極主動的策略不僅滿足了現代旅客不斷變化的需求，也預見了疫苗監管法規的潛在變化，從而確保市場環境的反應性和韌性。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術評估
• 監管環境

全球旅行疫苗市場規模（依疫苗類型分類）及複合年成長率（2026-2033 年）

• 單劑疫苗
• 聯合疫苗

全球旅行疫苗市場規模（按疾病和複合年成長率分類）（2026-2033 年）

• 甲型肝炎
• B型肝炎
• 傷寒
• 黃熱病
• 狂犬病
• 腦膜炎奈瑟菌
• 日本腦炎
• 麻疹和腮腺炎
• 其他

全球旅行疫苗市場規模（按旅行者類型分類）及複合年成長率（2026-2033 年）

• 海外旅客
• 入境旅客
• 商務旅行
• 休閒旅遊

全球旅行疫苗市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• GlaxoSmithKline plc
• Sanofi Pasteur
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Abbott Laboratories
• ALK-Abello A/S
• Bavarian Nordic A/S
• CSL Limited
• AstraZeneca plc
• Dynavax Technologies
• Emergent BioSolutions, Inc.
• Valneva SE
• Takeda Pharmaceutical Company
• Serum Institute of India Pvt. Ltd.
• Bharat Biotech International Ltd.
• Altimmune, Inc.
• LG Chem Ltd.（Life Sciences）
• Hualan Biological Engineering Inc.
• Mitsubishi Tanabe Pharma Corporation

結論與建議

Global Travel Vaccines Market size was valued at USD 4.31 Billion in 2024 and is poised to grow from USD 4.54 Billion in 2025 to USD 6.81 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The global travel vaccines market is experiencing significant growth due to multiple factors influencing both demand and supply dynamics. The surge in global travel for leisure, professional, and educational activities has heightened the need for region-specific vaccinations, essential for preventing local infections. The boom in global tourism, particularly eco-tourism and adventure travel, further underscores the necessity for protective immunizations. Increasing public and governmental awareness regarding outbreaks of infectious diseases enhances worldwide vaccine demand. Additionally, regulatory requirements in various countries for vaccination proof create compliance and market opportunities. Innovations in vaccine development techniques, including mRNA and recombinant technologies, are improving efficacy and accelerating production, thereby bolstering reliance on these vaccines. Rising healthcare costs and public health initiatives aimed at enhancing traveler education also contribute to market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Travel Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Travel Vaccines Market Segments Analysis

Global Travel Vaccines Market is segmented by Vaccine Type, Disease, Traveler Type and region. Based on Vaccine Type, the market is segmented into Mono Vaccines and Combination Vaccines. Based on Disease, the market is segmented into Hepatitis A, Hepatitis B, Typhoid, Yellow Fever, Rabies, Meningococcal, Japanese Encephalitis, Measles & Mumps and Others. Based on Traveler Type, the market is segmented into Outbound Travelers, Inbound Travelers, Business Travel and Leisure Travel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Travel Vaccines Market

A key market driver for the Global Travel Vaccines Market is the increasing prevalence of infectious diseases across various regions, alongside the rising demand for safe travel experiences. As international travel becomes more accessible, travelers are more aware of health risks associated with destination-specific diseases. This heightened awareness, combined with government initiatives to promote vaccination for travel-related diseases, propels the demand for vaccines. Moreover, the global push for vaccination in light of recent pandemics further enhances the necessity for travelers to obtain essential vaccinations, thereby driving the market's growth as both healthcare providers and travelers seek proactive measures to ensure health safety during travel.

Restraints in the Global Travel Vaccines Market

One significant market restraint for the global travel vaccines market is the rising hesitancy towards vaccination, driven by misinformation and cultural beliefs surrounding vaccines. This growing skepticism impacts travelers' willingness to receive necessary immunizations before travel, ultimately limiting the market's growth potential. Additionally, the increase in vaccine-related controversies and the spread of anti-vaccine sentiments through social media platforms further exacerbate public apprehension, leading to decreased vaccination rates. Consequently, healthcare providers may face challenges in promoting travel vaccines, as potential travelers prioritize their personal beliefs and misinformation over medical advice, hindering overall market expansion and public health initiatives.

Market Trends of the Global Travel Vaccines Market

The Global Travel Vaccines market is experiencing a significant transformation driven by the integration of advanced vaccine technologies, including mRNA, recombinant, and single-dose platforms. These innovations facilitate faster responses to emerging health threats while enhancing vaccine efficacy and optimizing distribution capabilities, owing to their stability. The efficacy of mRNA platforms was notably highlighted during the pandemic, prompting major pharmaceutical companies to invest in the research and development of new and combination travel vaccines. This proactive approach not only addresses the evolving needs of modern travelers but also anticipates potential shifts in vaccine regulations, ensuring a responsive and resilient market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Travel Vaccines Market Size by Vaccine Type & CAGR (2026-2033)

• Market Overview
• Mono Vaccines
• Combination Vaccines

Global Travel Vaccines Market Size by Disease & CAGR (2026-2033)

• Market Overview
• Hepatitis A
• Hepatitis B
• Typhoid
• Yellow Fever
• Rabies
• Meningococcal
• Japanese Encephalitis
• Measles & Mumps
• Others

Global Travel Vaccines Market Size by Traveler Type & CAGR (2026-2033)

• Market Overview
• Outbound Travelers
• Inbound Travelers
• Business Travel
• Leisure Travel

Global Travel Vaccines Market Size & CAGR (2026-2033)

• North America (Vaccine Type, Disease, Traveler Type)
  • US
  • Canada
• Europe (Vaccine Type, Disease, Traveler Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Disease, Traveler Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Disease, Traveler Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Disease, Traveler Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Pasteur
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALK-Abello A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bavarian Nordic A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynavax Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valneva SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech International Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altimmune, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LG Chem Ltd. (Life Sciences)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hualan Biological Engineering Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Tanabe Pharma Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations